ATE59656T1 - Heparansulfat-fraktionen, ihre herstellung sowie sie enthaltende mittel. - Google Patents

Heparansulfat-fraktionen, ihre herstellung sowie sie enthaltende mittel.

Info

Publication number
ATE59656T1
ATE59656T1 AT84108229T AT84108229T ATE59656T1 AT E59656 T1 ATE59656 T1 AT E59656T1 AT 84108229 T AT84108229 T AT 84108229T AT 84108229 T AT84108229 T AT 84108229T AT E59656 T1 ATE59656 T1 AT E59656T1
Authority
AT
Austria
Prior art keywords
effect
hydosanes
mucopolysaccharides
cells
molecular weight
Prior art date
Application number
AT84108229T
Other languages
English (en)
Inventor
Massimo Baldacci
Ugo Baldacci
Original Assignee
Baldacci Lab Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baldacci Lab Spa filed Critical Baldacci Lab Spa
Application granted granted Critical
Publication of ATE59656T1 publication Critical patent/ATE59656T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT84108229T 1983-07-13 1984-07-12 Heparansulfat-fraktionen, ihre herstellung sowie sie enthaltende mittel. ATE59656T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT22045/83A IT1163772B (it) 1983-07-13 1983-07-13 Oligosaccaridi eterogenei complessabili ed alfa-idosani ad attivita' terapeutica, procedimento per la loro preparazione e relative composizioni farmaceutiche
EP84108229A EP0134502B1 (de) 1983-07-13 1984-07-12 Heparansulfat-Fraktionen, ihre Herstellung sowie sie enthaltende Mittel

Publications (1)

Publication Number Publication Date
ATE59656T1 true ATE59656T1 (de) 1991-01-15

Family

ID=11190660

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84108229T ATE59656T1 (de) 1983-07-13 1984-07-12 Heparansulfat-fraktionen, ihre herstellung sowie sie enthaltende mittel.

Country Status (9)

Country Link
US (1) US5470965A (de)
EP (1) EP0134502B1 (de)
JP (1) JPS6038390A (de)
AT (1) ATE59656T1 (de)
AU (1) AU577300B2 (de)
CA (1) CA1277937C (de)
DE (1) DE3483801D1 (de)
IT (1) IT1163772B (de)
ZA (1) ZA845434B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1208509B (it) * 1985-03-13 1989-07-10 Mediolanum Farmaceutici Srl Processo per la produzione di eparan solfato e dermatan solfato naturali sostanzialmente puri eloro impiego farmaceutico.
US4847338A (en) * 1985-03-28 1989-07-11 University Of Iowa Research Foundation Low molecular weight heparin fragments as inhibitors of complement activation
AU7742591A (en) * 1990-04-06 1991-10-30 Washington University Anticoagulant oligosaccharides
US7259152B2 (en) 2000-06-07 2007-08-21 Alfa Wasserman, Inc. Methods and compositions using sulodexide for the treatment of diabetic nephropathy
US20040171819A1 (en) 2002-10-10 2004-09-02 Aventis Pharma S.A. Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3908004A (en) * 1970-05-20 1975-09-23 C L Basingstoke Limited Process for making injectable iron compositions for treating iron-deficiency anemia
IT1083903B (it) * 1977-08-09 1985-05-25 Lobo Srl Oligo-eteropolisaccaridi con attivita' eparinosimili,procedimento per il loro ottenimento e relative composizioni terapeutiche
SE449753B (sv) * 1978-11-06 1987-05-18 Choay Sa Mukopolysackaridkomposition med reglerande verkan pa koagulation, lekemedel innehallande densamma samt forfarande for framstellning derav
IL61201A (en) * 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
CA1171375A (en) * 1980-09-15 1984-07-24 Ulf P.F. Lindahl Oligosaccharides having selective anticoagulation activity
FR2535324A1 (fr) * 1982-10-27 1984-05-04 Choay Sa Station perfectionnee pour l'epuration d'eaux usees
IT1189298B (it) * 1982-06-18 1988-02-04 Manetti & Roberts Italo Brit Procedimento per produrre i glicosa minoglicani dermatansolfato ed eparan-solfato sostanzialmente puri e loro impiego farmaceutico
FR2538404B1 (de) * 1982-12-28 1985-08-23 Anic Spa
IT1195497B (it) * 1983-03-08 1988-10-19 Opocrin Spa Procedimento per la preparazione di frazioni oligosaccaridiche dotate di proprieta' farmacologiche per degradazione chimica di eparina

Also Published As

Publication number Publication date
EP0134502A1 (de) 1985-03-20
EP0134502B1 (de) 1991-01-02
CA1277937C (en) 1990-12-18
AU3053884A (en) 1985-01-17
IT8322045A1 (it) 1985-01-13
DE3483801D1 (de) 1991-02-07
AU577300B2 (en) 1988-09-22
JPS6038390A (ja) 1985-02-27
JPH0446281B2 (de) 1992-07-29
IT8322045A0 (it) 1983-07-13
ZA845434B (en) 1985-02-27
IT1163772B (it) 1987-04-08
US5470965A (en) 1995-11-28

Similar Documents

Publication Publication Date Title
ATE40555T1 (de) Verfahren zur organischen synthese von oligosacchariden,welche galactosamin- und uronsaeure-motive umfassen, oligosaccharide und ihre biologischen verwendungen.
CA1267495C (en) PURIFICATION AND ACTIVATION OF INSOLUBLE INCLUSION BODY PROTEINS
EA199700143A1 (ru) Способ и композиция ждя липидизации гидрофильных молекул
IL112585A (en) N-terminally chemically modified G-CSF and analogs process for their preparation and pharmaceutical compositions containing them
FI851231L (fi) Menetelmä ihmisen interleukiini-2:n talteensaamiseksi
DE3855523D1 (de) Proteine mit Faktor-VIII-Aktivität, Verfahren zu deren Herstellung unter Verwendung von genetisch modifizierten Zellen und diese enthaltende pharmazeutische Zusammensetzungen
DE69029033T2 (de) Polysaccharid-trenngele und gelsysteme für elektrophorese unter verwendung von sammelgel
ATE98376T1 (de) Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung.
ES506347A0 (es) Procedimiento de separacion de mezclas biologicas
EP0364690A3 (de) Alpha-Subeinheit des Mac-1-Leukocyt-Adhäsions-Rezeptors
IL91369A0 (en) Lfa-1alpha subunit and derivatives thereof free of natural contaminants,and pharmaceutical compositions containing it
DE3767311D1 (de) Thrombin bindender stoff und verfahren zu seiner herstellung.
ATE37564T1 (de) Reinigung von interleukin-2.
EP0160260A3 (de) Verfahren zur Immobilisierung von biologischem Material
GB1502320A (en) Water soluble bacterial extracts containing diaminopimelic acid obtained from corynebacteria
ATE59656T1 (de) Heparansulfat-fraktionen, ihre herstellung sowie sie enthaltende mittel.
PT77717B (de) Vinylencarbonat-polymerisate verfahren zu ihrer herstellung und ihre herstellung und ihre anwendung
ATE210695T1 (de) Verfahren zur herstellung von poly(diorganosiloxanen), mischungen, enthaltend diese poly(diorganosiloxane) und deren verwendung
ATE200518T1 (de) Hydroxyprolin reiche proteine und sie enthaltende pharmazeutische und kosmetische zubereitungen
ATE33253T1 (de) Verfahren zur herstellung von reinen dermatansulfat- und herapansulfatglykosaminoglukanen und ihre pharmazeutische verwendung.
AU678343B2 (en) Method and composition for determining the immunological activity of bioactive substances
ATE113062T1 (de) Throminbindende substanz und verfahren zu ihrer herstellung.
ATE164882T1 (de) Verfahren zur herstellung von aktivierten killer- monozyten und verfahren zur überprüfung ihrer tumoriziden aktivität
ATE3156T1 (de) Apoglucoseoxydase-zusammensetzung und ihre herstellung.
JPS57159485A (en) Base material for tissue cultivation

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee